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Abstract: Introduction: Pediatric patients cared for in professional healthcare settings are at high risk
of medication errors. Interventions to improve patient safety often focus on prescribing; however, the
subsequent stages in the medication use process (dispensing, drug administration, and monitoring) are
also error-prone. This systematic review aims to identify and analyze interventions to reduce dispensing,
drug administration, and monitoring errors in professional pediatric healthcare settings. Methods: Four
databases were searched for experimental studies with separate control and intervention groups, published
in English between 2011 and 2019. Interventions were classified for the first time in pediatric medication
safety according to the ”hierarchy of controls” model, which predicts that interventions at higher levels
are more likely to bring about change. Higher-level interventions aim to reduce risks through elimination,
substitution, or engineering controls. Examples of these include the introduction of smart pumps instead
of standard pumps (a substitution control) and the introduction of mandatory barcode scanning for drug
administration (an engineering control). Administrative controls such as guidelines, warning signs, and
educational approaches are lower on the hierarchy and therefore predicted by this model to be less likely to
be successful. Results: Twenty studies met the inclusion criteria, including 1 study of dispensing errors,
7 studies of drug administration errors, and 12 studies targeting multiple steps of the medication use
process. A total of 44 interventions were identified. Eleven of these were considered higher-level controls
(four substitution and seven engineering controls). The majority of interventions (n = 33) were considered
”administrative controls” indicating a potential reliance on these measures. Studies that implemented
higher-level controls were observed to be more likely to reduce errors, confirming that the hierarchy of
controls model may be useful in this setting. Heterogeneous study methods, definitions, and outcome
measures meant that a meta-analysis was not appropriate. Conclusions: When designing interventions to
reduce pediatric dispensing, drug administration, and monitoring errors, the hierarchy of controls model
should be considered, with a focus placed on the introduction of higher-level controls, which may be more
likely to reduce errors than the administrative controls often seen in practice. Trial Registration Prospero
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Introduction: Pediatric patients cared for in professional healthcare settings are at
high risk of medication errors. Interventions to improve patient safety often focus on
prescribing; however, the subsequent stages in the medication use process (dispensing,
drug administration, and monitoring) are also error-prone. This systematic review aims
to identify and analyze interventions to reduce dispensing, drug administration, and
monitoring errors in professional pediatric healthcare settings.
Methods: Four databases were searched for experimental studies with separate control
and intervention groups, published in English between 2011 and 2019. Interventions
were classified for the first time in pediatric medication safety according to the “hierarchy
of controls” model, which predicts that interventions at higher levels are more likely to
bring about change. Higher-level interventions aim to reduce risks through elimination,
substitution, or engineering controls. Examples of these include the introduction of
smart pumps instead of standard pumps (a substitution control) and the introduction
of mandatory barcode scanning for drug administration (an engineering control).
Administrative controls such as guidelines, warning signs, and educational approaches
are lower on the hierarchy and therefore predicted by this model to be less likely to
be successful.
Results: Twenty studies met the inclusion criteria, including 1 study of dispensing
errors, 7 studies of drug administration errors, and 12 studies targeting multiple steps
of the medication use process. A total of 44 interventions were identified. Eleven of
these were considered higher-level controls (four substitution and seven engineering
controls). The majority of interventions (n= 33) were considered “administrative controls”
indicating a potential reliance on these measures. Studies that implemented higher-level
controls were observed to be more likely to reduce errors, confirming that the hierarchy
of controls model may be useful in this setting. Heterogeneous study methods,
definitions, and outcome measures meant that a meta-analysis was not appropriate.
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Conclusions: When designing interventions to reduce pediatric dispensing, drug
administration, and monitoring errors, the hierarchy of controls model should be
considered, with a focus placed on the introduction of higher-level controls, which may
be more likely to reduce errors than the administrative controls often seen in practice.
Trial Registration Prospero Identifier: CRD42016047127.
Keywords: medication error, medication safety, child, pediatric, dispensing error, administration error, monitoring
error, hierarchy of controls
INTRODUCTION
The ongoing need to address medication safety and reduce
the risks to patients from their medications was recently
reinforced by the World Health Organization Technical
Report, “Medication Safety in High-Risk Situations”; the report
highlighted that adverse events resulting from medication errors
are now estimated to be the 14th leading cause of morbidity and
mortality in the world (1). In pediatric patients, pharmacokinetic
and pharmacodynamic parameters can be significantly different
from those in adults (2). As pediatric specific formulations are
often not available, adult formulations have to be manipulated
off-label before use (e.g., through crushing a tablet and taking
a portion from it). This results in an additional risk for
miscalculations (2). As a result, children are at an estimated three
times higher risk of potential adverse drug events than adults (3).
Medication errors are broadly defined as “any preventable
event that may cause or lead to inappropriate medication use
or patient harm while the medication is in the control of the
healthcare professional, patient, or consumer” (4). These events
may occur in every step of the medication use process (MUP).
Aitken et al. describe the MUP as four stages, starting with
prescribing, followed by preparation and/or dispensing of the
medication, and then drug administration and finally monitoring
for both therapeutic and adverse effects (5). The MUP is cyclical,
and depending on the outcomes of the monitoring process, the
decision may be made to either stop a medication or issue a
further prescription for the same or a different medication. It has
been suggested that the drug administration step of the MUP is
the most prone to error (5). Despite this, the current literature
focuses on interventions to prevent and/or reduce prescribing
errors, with a lesser focus on the subsequent stages of the MUP.
As the last overview of these interventions was published in 2014
(incorporating data up to November 22, 2011) (6), a follow-on
is needed. This review seeks to identify interventions designed
to reduce and/or prevent drug dispensing, administration, and
monitoring errors and determine their effect.
METHODS
Protocol and Registration
The protocol was registered in PROSPERO (reg. no.
CRD42016047127) and with the local ethics commission
(EK 158/17). To promote a differentiated focus on the individual
stages of the MUP, the results of the review were split post-hoc,
to consider interventions targeting prescribing errors in another
publication. The structure of this article was guided by the
recommendations of Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) (7).
Eligibility Criteria
Studies of interventions to reduce drug dispensing,
administration, and/or monitoring errors in professional
pediatric healthcare settings were included. An intervention was
defined as any action or set of actions implemented with the aim
of reducing medication errors. The definition of a medication
error from the “National Coordinating Council for Medication
Error Reporting and Prevention” was adopted, to provide a
broad classification and allow for the inclusion of as many
studies as possible (4). Definitions of dispensing errors, drug
administration errors, and monitoring errors adopted for this
review are provided in Table 1 along with their sources (8–10).
A professional healthcare setting was defined as all inpatient and
outpatient facilities where a healthcare professional is involved
in the MUP. Medication errors occurring when the medication
is in the care of the patient and/or their family are outside the
scope of this systematic review.
Five study types were included. Definitions from the
“Cochrane Effective Practice and Organization of Care Review
Group” were adopted for “randomized controlled trial,”
“controlled clinical trial,” “controlled before–after study,” and
“interrupted time–series study.” The fifth study type included
“uncontrolled before–after study,” defined as a study involving
a comparison of two patient groups, with and without the
investigated intervention.
Outcome parameters defined for the analysis were as follows:
intervention types and their impact on reducing dispensing,
drug administration, and/or monitoring errors according to each
article’s assessment.
Information Sources
The search strategy was adapted from the previous systematic
review by Rinke et al. (6) (see Supplementary Material 1).
Search
The analysis included the time span from November 22,
2011, to December 31, 2019, in order to provide a follow-
on from the previous systematic review (6). Previously piloted
terms were used to search CENTRAL, CINAHL, EMBASE, and
MEDLINE. Reference searching in the bibliographies of each
included article and selected reviews (6, 11–51) complemented
the aforementioned search.
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Study Selection
One reviewer (JK) assessed the resulting titles and abstracts using
a piloted form adapted from the form initially used by Rinke et al.
(6). Abstracts were evaluated according to 16 exclusion criteria
(see Supplementary Table 1). If none of the criteria were met,
the abstract was included in the screening of full texts against
these criteria. A second reviewer (AE) independently examined a
random 10% of the first reviewer’s search results of each database
using the same form. Interrater agreement was calculated via
Cohen κ (52).
Data Collection Process
Data extraction was performed using a piloted form, first by one
(JK) and then by a second reviewer (AE). Results were discussed
and amended if necessary. The results of the literature research
were analyzed using Excel 2016 (Redmond, WA, USA).
Data Items
Data collection included the interventions that were tested and
their reported effect, the study type, number and characteristics
of included patients, and the type of healthcare professionals
delivering the intervention(s).
Risk of Bias in Individual Studies
Bias risk was evaluated according to the COCHRANE tool for
randomized controlled trials, controlled clinical trials, controlled
before–after studies, and interrupted time–series studies (53,
54), whereas uncontrolled before–after studies were rated via
ROBINS-I (55).
TABLE 1 | Definitions of error subtypes.
Type of error Definition
Medication
error (ME)
“A medication error is any preventable event that may cause or
lead to inappropriate medication use or patient harm while the
medication is in the control of the healthcare professional,
patient, or consumer. Such events may be related to professional
practice, healthcare products, procedures, and systems,
including prescribing, order communication, product labeling,
packaging, and nomenclature, compounding, dispensing,
distribution, administration, education, monitoring, and use” (4).
Dispensing
error (DE)
“Any unintended deviation from an interpretable written
prescription or medication order. Both content and labeling
errors are included. Any unintended deviation from professional
or regulatory references, or guidelines affecting dispensing
procedures, is also considered a dispensing error” (8).
Administration
error (AE)
“Administration of a dose of medication that deviates from the
prescription, as written on the patient medication chart, or from
standard hospital policy and procedures. This includes errors in




“When a prescribed medicine is not monitored in the way that
would be considered acceptable in routine general practice. It
includes the absence of tests being carried out at the frequency
listed in the criteria, with tolerance of +50%” (10). This includes
monitoring after initiation and continuation of therapy.
Summary Measures
The impact of interventions was assessed through the calculation
of the error rate (based on each author’s definition of a
medication error) for the control and intervention groups. Based
on this, “absolute risk reduction” was established for each single
intervention or bundle of interventions. When insufficient data
were available to calculate separate error ratios for two study
groups, this was not undertaken, and the ratio of error before
and after intervention was calculated, based on the ratios given
by individual study authors (Table 2).
Synthesis of Results
Authors classified studies as either a “single-intervention study”
or a “bundle-intervention study,” according to whether or not
they implemented single or multiple interventions. The step(s)
in the MUP targeted by the interventions were identified, and
studies were also classified according to the errors they seek to
reduce, either dispensing, drug administration, or monitoring
errors individually or when they target multiple steps in theMUP
as investigating “combined medication errors.” For combined
medication error studies, the impact of interventions on MUP
steps other than prescribing was extracted for this analysis.
The individual interventions were classified according to a
hierarchical approach to risk control (76). It has been suggested
that this approach can aid in the identification of appropriate
interventions to reduce known risks occurring during risk-
prone processes, and it has been hypothesized that this approach
could be successfully adopted in the healthcare setting (77). The
highest (most likely to be successful) level of control involves
eliminating the risk entirely; the next level suggests making a
substitution, so that a risk is reduced when it is not possible
to eliminate it (e.g., the substitution of manually operated
infusion pumps with smart pumps containing a drug database).
Engineering controls are next on the hierarchy and involve
attempts to isolate a risk or to isolate a patient from a risk. For
example, barcoded drug administration is an engineering control,
which aims to reduce the risks of patients receiving the wrong
medication via mandatory scanning a patient wristband and/or
the medication to be given; if either is false, this is highlighted
to the healthcare professional administering the medication,
and they are prevented from proceeding to document the
administration. This step is followed by administrative controls,
which often include informative signage and education; personal
protective equipment completes the hierarchical approach, as
the lowest level of control. Figure 1 displays the “hierarchy
of controls” with medication safety–related examples for each
level. For analysis, elimination, substitution, and engineering
controls were combined and considered as higher-level controls,
to be compared with the lower levels of control (administrative
controls and personal protective equipment). This division into
higher- and lower-level controls was performed in analogy to the
methods presented by Card et al. (78).
The classification of interventions was performed
independently by two authors (JK, NY). Interrater agreement
was calculated via weighted Cohen κ (52). Discrepancies were
discussed and resolved by a third author (AE) when necessary.

































TABLE 2 | Summary of study characteristics.
Studies addressing one step in the medication use process
First author
(country, year)
Error type(s) Study design,
study centers
Setting Methods Intervention Single/bundle
intervention





















(75% and 71%, respectively)
(1) Standardized preparation
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medication preparation,


























NICU Direct observation of
ward-based preparation and
application of drugs by trained
pharmacy students for 10




a standardized data collection
form in pilot phase; each
medication dose observation
could contain more than one
error
Educational program
consisting of an 1-h
teaching session and
30-min individual practical






























Direct observation of drug
administration by pharmacists










Single Pre: 1,284 doses
observed for 217
patients (5.9 doses per
patient) with 569 doses
containing at least one
error (852 errors total);
post: 1,401 doses for
208 patients (6.7 doses
per patient) with 400
doses containing at




















































































TABLE 2 | Continued
Studies addressing one step in the medication use process
First author
(country, year)
Error type(s) Study design,
study centers
Setting Methods Intervention Single/bundle
intervention




















Single Pre: 9.8 errors per
10,000 doses
dispensed; post: 8.2











EP Assessment of missed or




separation of medications into
“urgent” (medication for































Direct observation by four
trained pharmacists using a
predefined 22-item list of
drug-handling processes;
monitoring in the morning















Single Patients: CG: 38/43























PICU Direct observation by five














Single Patients: CG: 36/38





























































































TABLE 2 | Continued
Studies addressing one step in the medication use process
First author
(country, year)
Error type(s) Study design,
study centers
Setting Methods Intervention Single/bundle
intervention
















10:00 a.m. – 6:00 p.m. and
10:00 p.m. – 6:00 a.m.);
assessment of a deviation
between the physician’s order
and the administered
medication
(1) Written alerts displayed
on the door of the
preparation room
















between CG and IG)
28.17%/21.44% 6.73% (significantly
positive results)

















100 medical files were
randomly selected on a
pediatric medical ward per
month over a period of 9
months; it was aimed at
reducing drug-related
problems in each of the three
selected steps of the
medication use process
prescribing, administration,
and monitoring steps to





(2) Implementation of a
clinical pharmacist into the
medical team
(3) Establishment of drug
information center
(4) Establishment of IV
admixture unit
(5) Using auxiliary labels
Bundle 900 medical files
reviewed (100 files per
month); prescribing
errors: CG (1st month):
47 errors/ 100 files, IG
(9th month): 10 errors/
100 files; drug
administration errors:
CG (1st month): 60
errors/ 100 files, IG (9th
month): 10 errors/ 100
files; monitoring errors:
CG (1st month): 56
errors/ 100 files, IG (9th


























































































TABLE 2 | Continued
Studies addressing multiple steps in the medication use process (combined medication errors)
First author
(country, year)
Error type(s) Study design,
study centers
Setting Methods Intervention Single/bundle
intervention















EP Retrospective ME analysis of
medical records (drug choice,
dosage deviation >10% of
recommended dosing,
frequency, and route of
administration) for children
<18 years, who were treated
for anaphylaxis in the
emergency department
Standard order form for
medications used in
anaphylaxis




















NICU A retrospective EMR chart
review of children with a birth
weight <2 kg and a
hospitalization of ≥58 days
were included in the time
range of 2009–2013. The
2-month immunization status
was investigated for the seven
vaccines recommended
An electronic immunization
alert was introduced into the
EMR. It was shown from
days 56 to 67 on the
beginning of the day to the
physicians and nurses
separately
Single CG: 35 infants partially
immunized or
unimmunized/121





























Single Pre: 312 medication
errors were detected in























EP Ward pharmacist reviewed
medication orders in the
emergency department on
weekdays from 3 to 11 pm;
assessment of ME rates in
three 3-month intervals
3-h educational program for
emergency department
residents, led by an
attending physician and the
ward pharmacist






















































































TABLE 2 | Continued
Studies addressing multiple steps in the medication use process (combined medication errors)
First author
(country, year)
Error type(s) Study design,
study centers
Setting Methods Intervention Single/bundle
intervention



















Analysis of MEs that resulted
in patient harm (NCC MERP
type D-I) through assessment
















(5) A “distraction-free zone”
consisting of a physical mat
in front of the PYXIS and
signs placed on the
computers in the unit
(6) Bedside
medication barcoding
Bundle 33 pADEs that resulted
in patient harm in 2010;
3 pADEs in 2011; 6
pADEs in 2012; and 4
pADEs in 2013;
harm-causing pADEs
were reduced from 0.43






















PICU Clinical records and the
incident reporting system of a
PICU were reviewed for
medication errors. When an
error was suspected, a
pediatric intensivist, and a
clinical pharmacist reviewed






intensivists on a PICU. A
clinical pharmacist was
present on ward 3 h 5 days
per week. PICU-patients





more than 5 medications,
and (e) medication
prescriptions with which the
PICU professionals felt
unfamiliar” were included.
Single Pre: within 1 year, 254
patients were admitted





errors); post: within 1
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TABLE 2 | Continued
Studies addressing multiple steps in the medication use process (combined medication errors)
First author
(country, year)
Error type(s) Study design,
study centers
Setting Methods Intervention Single/bundle
intervention



















directly observed for 2
months regarding the drug
handling and medication
errors in the operating room.
Using this data, a
failure-mode-and-effect
analysis was performed to
develop interventions,





and sequesters; due to
high-risk medications, and
according to the frequency
of usage)







(4) Infusion double check
(independent double check,
documented with preprinted
labeling tape on the infusion)
(5) Medication practice
guideline (developed and
posted in every operating
room: syringe labeling,
medication preparation)
Bundle Pre: 368 syringes for 68
patients were audited
with 101 labeling errors






post: 402 syringes for
61 patients were
audited with 16 labeling
errors within 2 months.

























Entire hospital Within a pediatric hospital, a
quality improvement initiative
was implemented to reduce
harm-causing medication
errors (NCC MERP D-I) in a
4-year study period. The
initiative rendered
interventions to all aspects of
the medication use process
with a special focus on
administration errors. Error
data was recorded from
voluntary incident reporting,
trigger tool analysis, reversal





(2) Implementation of a
wireless nurse
communication system
(3) Smart syringes and
pumps with drug libraries
(4) Safety nurse-led audits
of the compliance to the 5
rights
medication administration
(5) Implementation of a
barcoded
medication administration
(6) Pharmacy has more
pneumatic tubes for faster
delivery of compounded
urgent medications
Bundle In the 1st quarter 2010,
the number of pADEs
maximized to 85 within
3 months (0.171 pADE
per 1000 dispensed
doses). In the last
investigated quarter
(2nd quarter 2013), this
number was reduced to






















































































TABLE 2 | Continued
Studies addressing multiple steps in the medication use process (combined medication errors)
First author
(country, year)
Error type(s) Study design,
study centers
Setting Methods Intervention Single/bundle
intervention




















accreditation in 2014 was
sought. Therefore, a training
program for the JCI standards
to preclude prescribing and
administration errors was




ward medical charts were
performed
Educational program
consisting of lectures, a
personal handbook, and an
educational software. Topics
discussed were prescribing
of an accurate order, filling it
by the nurse, supervising it
by the nurse and
pharmacist, and handling of
a medication error
Single Pre: during 1 month,
183 patients were
included, they got 937
prescription and 924
administration orders;
61 prescribing and 104
administration errors
occurred; post: during 1
month, 183 patients

























Retrospective chart review of
1 year of prescriptions and
medication dispensing
records of physicians and
pharmacists in an emergency
department of a tertiary
hospital
A voice recognition system
was installed at one
computer in the emergency
department. A medical
dictionary was developed
and stored in a computer
database; voice profiles
were installed; training with
the system was provided for
the users







patients with 889 errors.
In the same period,
1,111 dispensations
with 1,030 errors were
documented; post: 501
prescriptions were
written for 501 patients






reduction was seen in
the dose prescription.
pharmacists criticized
that no drug database
existed—this may have



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The interventions were then grouped descriptively to provide a
practical overview of possible interventions at each control level.
Group comparisons were calculated using Fisher exact test
(level of significance: p < 0.05) or Mann–Whitney U-test
(two-tailed, p < 0.05), whatever was applicable.
Initially planned meta-analyses were deemed unfeasible
because of heterogeneity in study designs, outcomes, the high
number of uncontrolled before–after studies, and the high
proportion of studies using a bundle of interventions, meaning
the influence of one specific intervention cannot be quantified.
Risk of Bias Across Studies
All studies meeting the inclusion criteria were included,
regardless of whether they reported positive, neutral, or negative
results. It was assumed that there was an equal distribution for
each group in case of no bias.
It has been reported that positive study results are often
published sooner than non-significant or negative results,
producing a time-lag bias (79, 80). Within this review, time to
publication was assessed for each study using the time from
date of data completion to the date of electronic publication
(81, 82). Studies were grouped according to their results:
into studies with significantly positive results (studies which
statistically significantly reduced error rates), non-significantly
results (reduced or increased error rates observed, but statistical
significance not demonstrated), or mixed results. No studies
demonstrating significantly negative results (increased error
rates) were identified. Statistical differences were calculated using
Mann–Whitney U-test (see above).
Additional Analyses
Definitions of medication errors were recorded and compared,
following previous reports relating to heterogeneity of definitions
(6, 11, 16, 83, 84), which can lead to poor comparability
of studies. A definition was recorded when the authors of a
study clearly identified that a definition had been used (e.g.,
“medication error was defined as. . . ”). Authors searched all
included studies for definitions of medication error, dispensing
error, drug administration error, and monitoring error.
Whether or not the error types investigated in each study were
clearly defined by the study authors was also assessed.
RESULTS
Study Selection
The original search strategy was intended to identify studies
investigating interventions to reduce pediatric medication errors
during all stages of the MUP; the results were split post-
hoc to address the challenge of managing dispensing, drug
administration, and monitoring errors separately to prescribing
errors. Database searches identified 5,440 abstracts, which were
reviewed by the first reviewer (JK) and resulted in 50 full
texts that corresponded to the full inclusion criteria. A second
reviewer (AE) independently assessed 547 randomly selected
abstracts. This resulted in an “excellent agreement” of both
reviewers (Cohen κ = 0.86) (52). The search of the bibliographies
of the included full texts as well as systematic and narrative
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FIGURE 1 | “Hierarchy of controls” with examples for each stage. PPE, Personal protective equipment. Adapted from: National Institute for Occupational Safety and
Health (NIOSH) (76).
reviews (n = 4,039 abstracts) led to four additionally included
publications [see PRISMA flowchart (7), Figure 2]. Of the initial
search results, 20 studies met the inclusion criteria for this review,
in that they investigated interventions to reduce dispensing, drug
administration, and/or monitoring errors.
Study Characteristics
The 20 selected studies (56–75) originated from 11 countries
and 4 continents (Table 2), with the majority being completed in
North America (9/20, 45%). One controlled clinical trial and two
interrupted time–series studies were identified; the majority of
studies (n = 17; 85%) were classed as uncontrolled before–after
studies. All studies addressed the hospital setting, with a focus
on inpatient care (n = 15, 75%). Nineteen studies (95%) were
single-center studies.
Risk of Bias Within Studies
The summarized data of bias risk assessment are shown in
Figures 3–5 and Supplementary Tables 2–4. All uncontrolled
before–after studies had a serious or critical risk for bias due to
a non-declaration of possible confounders.
Results of Individual Studies
The results of the individual studies are summarized in Table 2.
Synthesis of Results
Interventions
A total of 44 different interventions were identified, which aim
to reduce errors at one or more of the three included MUP
stages. Eight of the included studies investigated interventions
for a single point in the MUP, either dispensing or drug
administration. No studies addressed monitoring errors
independently of other MUP stages. The remaining 12 studies
investigated interventions to reduce errors at more than one
stage in the MUP and were therefore classified as combined
medication error studies. The interventions in these studies,
which were believed to address dispensing, drug administration,
and/or monitoring, were extracted for descriptive analysis.
Fourteen studies, including 34 interventions, achieved a
statistically significant reduction in error rate, according to the
definition of the individual study authors, 3 studies showed a
statistically non-significant difference in error rates, and the
remaining 3 studies reported mixed results.
Interventional Approach of the Studies
In the majority of studies (n = 13), the impact of a
single intervention was investigated, whereas seven studies
implemented a bundle of interventions. A non-statistically
significant preference (p= 0.28) for a bundle of interventions was
observed in studies targeting more than one stage of the MUP
(42% of combined medication error studies used a bundle of
interventions compared with 28% of studies investigating a single
step in the MUP).
Single-Intervention Studies
Only one study investigated dispensing errors at pharmacy
level, independent of other stages in the MUP. This study used
a single intervention in the form of the implementation of
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FIGURE 2 | PRISMA flowchart reporting study selection.
a new electronic workflow system, which interfaced with the
electronic prescribing system already in place and demonstrated
a significant reduction in error rate (59).
Five of seven studies addressing drug administration errors
implemented a single intervention. Marconi et al. investigated
the impact of a clinical pharmacist working in an emergency
department with the aim of reducing missed or delayed
medications and demonstrated an absolute risk reduction of
17.4% (60). The remaining four single-intervention studies
targeting drug administration errors implemented educational
approaches: Chedoe et al. combined practical and theoretical
preparation and administration techniques in one educational
intervention for nurses on a neonatal intensive care unit (absolute
risk reduction 17.9%) (57). Chua et al. used a pharmacist-led
program involving observation of drug administration by the
pharmacist followed by feedback and education to nursing
and medical staff regarding observed risks or errors (absolute
risk reduction 15.8%) (58). Niemann et al. implemented a
similar educational program in two different settings; a short
handout was combined with a lecture and a handbook for
nurses on a pediatric ward and on a pediatric intensive
care unit (absolute risk reduction 7.1 and 41.0%, respectively)
(61, 62).
The single interventions implemented in the seven studies
targeting multiple steps of the MUP included educational
approaches (4/7), the use of computerized reminders, and the
standardization of documentation (65–68, 70, 73, 74). Three of
these reached significantly positive results (65, 66, 70).
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FIGURE 3 | Bias risk assessment for included CCT (n = 1).
FIGURE 4 | Bias risk assessment for included ITSs (n = 2).
Bundles of Interventions
Seven studies introduced a bundle of interventions, namely, more
than one interventional method to address one or more stages
in the MUP. Bundles of interventions were wide ranging and
often included an element of education (56, 63, 64, 69, 71, 72, 75).
The effect of a single intervention could not be calculated as the
effects described in the studies were the result of the combination
of interventions.
Classification of Interventions According to the
Hierarchy of Controls
Two authors independently classified the 44 identified
interventions according to the hierarchy of controls. Before
discussion, agreement was 72% [weighted κ = 0.45, “fair”
agreement (52)]. After discussion, complete consensus
was reached.
No studies were identified that eliminated the risk of error;
in addition, only four interventions (9%) were rated as having
made a substitution, for example, of equipment, with the aim
of reducing the risk. Seven interventions (16%) were considered
engineering controls, for example, the introduction of barcoded
drug administration, whereas the vast majority of interventions
were classified as “administrative controls” (33/44 interventions,
75%), such as educational programs, policies, guidelines, and
warning signs (Figure 6).
Of the 44 identified interventions, 34 were implemented in
the 14 studies that achieved a significant reduction in error rate.
Three of the interventions involved in studies with reduced error
rates were categorized as substitution controls, 7 as engineering
controls, and 24 as administrative controls (Table 3).
Six of the seven studies that implemented higher levels
of control (substitution or engineering controls) resulted in
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FIGURE 5 | Bias risk assessment for included UBAs (n = 17).
FIGURE 6 | Forty-four interventions resulting from 20 studies were categorized to the “hierarchy of controls”. Adapted from: National Institute for Occupational Safety
and Health (NIOSH) (76).
a significant reduction in error rate (86%). In contrast,
only 8 of 13 studies where solely administrative controls
were implemented reported significant error reductions (62%).
Thus, studies that implemented substitution or engineering
controls were 1.4 times more likely to result in reduced
error rates compared to administrative controls implemented
alone (86:62 = 1.4). This difference failed to reach statistical
significance (p = 0.23). Studies that implemented substitution
or engineering controls lasted a median of 49 months to
collect control- and intervention-group data, whereas studies of
administrative controls had a median duration of 4 months. The
difference between these median study durations was significant
(Mann–Whitney, p < 0.05, two-tailed), demonstrating that the
effects of administrative controls have been tested over shorter
time periods, so the longevity of their effects is more difficult
to establish.
Substitution controls included the introduction of a new
pharmacy admixture unit, the introduction of smart pumps, and
the use of standardized dilutions (64, 72, 75). These substitutions
all formed part of successful bundles of interventions, which
led to significantly reduced error rates in combined medication
error studies. The introduction of voice-recorded and printed
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TABLE 3 | Summary of interventions that were implemented in studies that
significantly reduced medication errors (34 interventions of total 44 identified









Substitution n = 3 Standardized dilutions (75)








equipment (2×) (69, 72)
Barcoded medication




n = 24 Education and/or practical training
(8×) (56–58, 61, 64, 69, 72)*
Guidelines or protocols (6×)
(56, 63, 65, 69, 72, 75)
Rearrangement of staff or




Warning signs (3×) (63, 69)§
*Keiffer et al. implemented two different educational interventions (medication error
huddles and “5 rights education”).
†
Ozkan et al. implemented two different rearrangement interventions (decrease of patient-
to-nurse ratio and modified delivery time of medications).
‡
Abuelsoud et al. implemented two different expert consultation interventions
(implementation of a clinical pharmacist within the medical team and a drug
information service).
§Ozkan et al. implemented two different warning sign interventions (written alert on the
door of the preparation room and signaling arm bands for medication-preparing nurses).
prescriptions did not lead to a reduced rate of dispensing
errors (74).
Seven engineering controls were identified within four
different studies (59, 66, 69, 72); five of these controls
were implemented as parts of bundles of interventions,
alongside administrative controls. They were demonstrated in
all cases to be effective through a significant reduction in
errors. Interventions included the introduction of a workflow
management system, additional supplies to facilitate the use
of pneumatic tubes, hands-free communication systems, and
barcoded drug administration. Alerts in the patient electronic
medical record were also successful on this occasion, although
carefully implemented to reduce the risk of alert fatigue, which
was acknowledged by the authors.
The overwhelming majority of interventions identified were
classified as administrative controls. They could be subdivided
into “education and training” (n= 12), “guidelines, protocols and
procedures” (n = 8), “rearrangement of staff/material” (n = 6),
“expert consultations” (n= 4), and “warning signs” (n= 3).
Risk of Bias Across Studies
Based on the high percentage of significantly positive results
(70%), a publication bias could not be ruled out.
Sixteen studies (80%) reported a date when data collection
was completed, allowing the calculation of time to publication.
Studies reporting significantly positive results were published
after a median of 26 months (interquartile range = 17.5–37
months), whereas mixed results were published after a median
of 39 months (interquartile range = 33.25–44.5 months). When
compared to the distribution of significant positive results, a
statistically significant difference could not be confirmed.
Additional Analyses
In 14 of 20 full texts, 16 definitions were identified within 44
opportunities for definition (36%, see Supplementary Table 5).
Seven definitions of a medication error (35% of all included full
texts), one definition of a dispensing error (33% for a total of
3 full texts), seven definitions of a drug administration error
(39%, total: 18 studies), and one definition of a monitoring error
(33% for a total of 3 full texts) were identified. These definitions
were heterogeneous in content and often failed to consider the
patient; e.g., the definition for “medication error” contained only
in one case the phrase “preventability”; the definitions for “drug
administration error” did not contain any patient-centered aspect
and had instead a technical focus.
DISCUSSION
Summary of Evidence
We identified 44 individual interventions designed to reduce
dispensing, drug administration, and monitoring errors and
classified them according to a hierarchical approach to risk
control. This is, to our knowledge, the first review to use
the hierarchy of controls model to classify interventions for
improving pediatric medication safety. This model, adapted
from the health and safety industry, suggests that interventions
should first be sought at the highest level of control (elimination
of risk) before other options that are lower on the hierarchy
and therefore potentially less effective are considered (78, 85).
Although none of the interventions identified in this review were
classified by the authors at the highest level (elimination), our
results do support the theory that interventions at higher levels
(substitution and engineering) should be prioritized, through
the observation that studies implementing higher-level controls
were 1.4 times more likely to achieve a significant reduction in
error rates than those using administrative controls only. This
is in line with the findings of Card et al., who reported a ratio
of 1.6 (78). Despite this, we have observed that administrative
controls are more frequently implemented, indicating a potential
opportunity to rethink our approach to risk reduction and quality
improvement, with a focus first on the opportunities to substitute
risks or use engineering controls (77, 78), in favor of the perhaps
easier-to-implement administrative controls.
There are criticisms of the use of a hierarchical control model
in this setting. The lack of consideration of the potential human
factors involved in medication errors has been cited as a key
challenge (86), and Liberati et al. judged that “this model adds
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little value to the development of effective risk controls in clinical
settings and lacks validity and usefulness” (87). The possibility
of truly eliminating risks from the MUP can also be questioned,
because omission of one or more medications would in itself be a
risk to the patient (88). Practically seen, we may therefore expect
interventions, which substitute a risk-prone process or step with
a lower-risk option to be the strongest type of intervention
available to us in the field of medication safety. We suggest that
the hierarchy of controls model could be a useful tool to prompt
those designing interventions to first consider the higher levels of
control, before opting to implement administrative controls. We
must, however, also acknowledge that the complexity of theMUP
requires the use of a wider range of quality improvement tools
and methodologies in order to design effective interventions,
which also take local factors into consideration (85).
The wide range of interventions identified in this review at
the higher levels of control supports this consideration. These
interventions can be broadly considered as fitting into one of
two groups. The first group includes interventions that interact
with electronic medical records or electronic prescribing systems,
which were already in place in the included studies (59, 66, 69,
72). On this basis, we would suggest that electronic prescribing
and patient records provide a good foundation on which other
interventions can be developed. The second group of higher-
level interventions includes those that interact with the working
environment, often with the aim of reducing interruptions
and/or redistributing workload among the multidisciplinary
team, for example, medication production being carried out by
the pharmacy team in a specialized unit, rather than by the
nursing team on the ward (64, 69, 72, 75). These improvements
may lead to reduced error-producing conditions and in turn to
improved pediatric medication safety (89).
The majority of the identified interventions were classified
as administrative controls. Interestingly, we noted that these
measures were often implemented alongside higher-level
controls, as parts of bundles of interventions. In these studies, it is
not possible to separate the influence of individual interventions
within the bundle, and we must therefore acknowledge the
potential importance of administrative controls including
education, guidelines, and protocols when implemented
alongside higher-level interventions.
In the review at hand, similar limitations of the currently
published literature were identified as have been shown in
previous systematic reviews in the field (6, 11, 34, 44). The
included publications mainly originated from North America
or Europe; the studies were performed primarily in inpatient
settings, and the identified definitions of central terms were
of heterogeneous nature. These factors should be considered,
particularly when planning future research projects in this area.
STRENGTH AND LIMITATIONS
We used the hierarchy of controls model for the first time
to classify interventions to reduce pediatric dispensing, drug
administration, and monitoring errors and have demonstrated
that this model may be an appropriate tool for use in this setting.
Our methodology is potentially limited as the initial
data extraction was performed by one researcher, with
corrections and/or additions being provided by a second
independent reviewer. As most studies were uncontrolled
before–after studies and therefore present a high risk of
bias, the results should be interpreted with caution. The
inclusion criteria comprised studies published in English
only, leading to a potential foreign language bias, although
evidence for this is questionable (90). In addition, this
review includes experimental studies for an 8-year time
span only and must therefore be interpreted alongside the
results of previous, and future subsequent, reviews on the
same topic.
CONCLUSION
When designing interventions to reduce pediatric dispensing,
drug administration, and monitoring errors, the hierarchy of
controls model should be considered, with a focus placed on
the introduction of higher-level controls, which may be more
likely to reduce errors than the administrative controls often
seen in practice. A wide range of approaches to addressing the
risks of dispensing and administering medications for pediatric
patients in inpatient professional healthcare settings has been
identified, and it is important to consider local conditions when
planning interventions.
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